New Indication: Trastuzumab deruxtecan for her2+ NSCLC
|New Indication: Trastuzumab deruxtecan for her2+ NSCLC|
N Engl J Med. 2022; 386:241-251
Li BT, et al. Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
Reviewed by Hasan Cagri Yildirim, MD on Sep 30, 2021
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.